Effects of Gastrointestinal Symptoms on the Efficacy of Washed Microbiota Transplantation in Patients with Autism

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2025 Feb 28

PMID 40017709

Authors

Dong-Xia Hu

Cai-Mei Lu

Xin-Yu Si

Qing-Ting Wu

Li-Hao Wu

Hao-Jie Zhong

Xing-Xiang He

Affiliations

Soon will be listed here.

Abstract

Objective: Washed microbiota transplantation (WMT) has emerged as a promising therapeutic strategy for autism spectrum disorder (ASD), though the factors that influence its efficacy remain poorly understood. This study explores the impact of gastrointestinal (GI) symptoms on the effectiveness of WMT in ASD.

Methods: Clinical data encompassing ASD symptoms, GI disturbances, and sleep disorders were collected from patients with ASD undergoing WMT. The therapeutic impact of WMT and the contributing factors to its efficacy were assessed.

Results: WMT significantly reduced scores on the Aberrant Behavior Checklist (ABC), Childhood Autism Rating Scale (CARS), and Sleep Disturbance Scale for Children (SDSC), alongside a significant reduction in the incidence of constipation, abnormal stool forms, and diarrhea (all < 0.05). After six courses of WMT, substantial reductions were observed in ABC, CARS, and SDSC scores, with increased treatment courses correlating with greater improvement ( < 0.05). Multiple linear regression analysis revealed that WMT efficacy was enhanced in patients with pre-existing GI symptoms (diarrhea: = 0.119, < 0.001; abnormal stool form: = 0.201, < 0.001) and those receiving a higher number of treatment courses ( = 0.116, < 0.001). Additionally, the analysis indicated that treatment outcomes were more favorable in patients who had not undergone adjunct interventions ( = -0.041, = 0.002), had a longer disease duration ( = 0.168, = 0.007), and exhibited more severe disease symptoms ( = 0.125, < 0.001).

Conclusion: WMT significantly alleviates both ASD and GI symptoms, along with sleep disturbances, in affected individuals. Six treatment courses resulted in notable improvement, with increased course numbers further improving therapeutic outcomes. Furthermore, pre-treatment GI symptoms, such as diarrhea and abnormal stool forms, may influence the effectiveness of WMT. Notably, patients who did not receive additional interventions, had a prolonged disease duration, and presented with more severe symptoms experienced markedly improved treatment responses.

References

Liu N, Liu H, Zheng J, Zhu M, Wu L, Pan H . Fresh Washed Microbiota Transplantation Alters Gut Microbiota Metabolites to Ameliorate Sleeping Disorder Symptom of Autistic Children. J Microbiol. 2023; 61(8):741-753. DOI: 10.1007/s12275-023-00069-x. View

Choi G, Yim Y, Wong H, Kim S, Kim H, Kim S . The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016; 351(6276):933-9. PMC: 4782964. DOI: 10.1126/science.aad0314. View

Sharon G, Cruz N, Kang D, Gandal M, Wang B, Kim Y . Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell. 2019; 177(6):1600-1618.e17. PMC: 6993574. DOI: 10.1016/j.cell.2019.05.004. View

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J . Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2010; 25(1):40-5. PMC: 2991432. DOI: 10.1016/j.bbi.2010.08.003. View

Xiao L, Yan J, Yang T, Zhu J, Li T, Wei H . Fecal Microbiome Transplantation from Children with Autism Spectrum Disorder Modulates Tryptophan and Serotonergic Synapse Metabolism and Induces Altered Behaviors in Germ-Free Mice. mSystems. 2021; 6(2). PMC: 8547010. DOI: 10.1128/mSystems.01343-20. View

Zhang Y, Zhang J, Pan Z, He X . Effects of Washed Fecal Bacteria Transplantation in Sleep Quality, Stool Features and Autism Symptomatology: A Chinese Preliminary Observational Study. Neuropsychiatr Dis Treat. 2022; 18:1165-1173. PMC: 9199912. DOI: 10.2147/NDT.S355233. View

Volkmar F, Cicchetti D, Dykens E, SPARROW S, Leckman J, Cohen D . An evaluation of the Autism Behavior Checklist. J Autism Dev Disord. 1988; 18(1):81-97. DOI: 10.1007/BF02211820. View

Moayyedi P, Surette M, Kim P, Libertucci J, Wolfe M, Onischi C . Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. Gastroenterology. 2015; 149(1):102-109.e6. DOI: 10.1053/j.gastro.2015.04.001. View

Liang F, Song Y, Lin D, He H, Xu J, He X . Washed Microbiota Transplantation Is Associated With Improved Lipid Profiles: Long-Term Efficacy and Safety in an Observational Cohort From South China. Clin Transl Gastroenterol. 2024; 15(7):e00735. PMC: 11272356. DOI: 10.14309/ctg.0000000000000735. View

10.

Lu G, Wang W, Li P, Wen Q, Cui B, Zhang F . Washed preparation of faecal microbiota changes the transplantation related safety, quantitative method and delivery. Microb Biotechnol. 2022; 15(9):2439-2449. PMC: 9437882. DOI: 10.1111/1751-7915.14074. View

11.

Wei J, Chen J, Fang X, Liu T, Yuan Y, Zhang J . Protocol for the safety and efficacy of fecal microbiota transplantation liquid in children with autism spectrum disorder: a randomized controlled study. Front Microbiol. 2023; 14:1236904. PMC: 10477363. DOI: 10.3389/fmicb.2023.1236904. View

12.

Hui W, Li T, Liu W, Zhou C, Gao F . Fecal microbiota transplantation for treatment of recurrent C. difficile infection: An updated randomized controlled trial meta-analysis. PLoS One. 2019; 14(1):e0210016. PMC: 6343888. DOI: 10.1371/journal.pone.0210016. View

13.

Vargason T, McGuinness D, Hahn J . Gastrointestinal Symptoms and Oral Antibiotic Use in Children with Autism Spectrum Disorder: Retrospective Analysis of a Privately Insured U.S. Population. J Autism Dev Disord. 2018; 49(2):647-659. PMC: 6365214. DOI: 10.1007/s10803-018-3743-2. View

14.

Wu X, Ai R, Xu J, Wen Q, Pan H, Zhang Z . Washed microbiota transplantation for Clostridioides difficile infection: A national multicenter real-world study. J Dig Dis. 2023; 24(10):540-549. DOI: 10.1111/1751-2980.13227. View

15.

Li N, Chen H, Cheng Y, Xu F, Ruan G, Ying S . Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. Front Cell Infect Microbiol. 2021; 11:759435. PMC: 8560686. DOI: 10.3389/fcimb.2021.759435. View

16.

Kang D, Adams J, Coleman D, Pollard E, Maldonado J, McDonough-Means S . Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci Rep. 2019; 9(1):5821. PMC: 6456593. DOI: 10.1038/s41598-019-42183-0. View

17.

Lou M, Cao A, Jin C, Mi K, Xiong X, Zeng Z . Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorder. Gut. 2021; 71(8):1588-1599. PMC: 9279844. DOI: 10.1136/gutjnl-2021-325115. View

18.

Schopler E, Reichler R, DeVellis R, Daly K . Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord. 1980; 10(1):91-103. DOI: 10.1007/BF02408436. View

19.

Randall M, Egberts K, Samtani A, Scholten R, Hooft L, Livingstone N . Diagnostic tests for autism spectrum disorder (ASD) in preschool children. Cochrane Database Syst Rev. 2018; 7:CD009044. PMC: 6513463. DOI: 10.1002/14651858.CD009044.pub2. View

20.

Kang D, Adams J, Gregory A, Borody T, Chittick L, Fasano A . Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome. 2017; 5(1):10. PMC: 5264285. DOI: 10.1186/s40168-016-0225-7. View